ARCHIVES

Tumor Classification, Monoclonal Antibody Announcements Made

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010

DCPC Begins Reassessment of Year 2000 Goals; Advisors Discuss A ‘More Dynamic Model’

May 22, 1992

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

FDA claims news coverage violated privacy of applicants for oncology job.

March 4, 2005